You are here

Article Text

Article menu

Download PDFPDF

A malignant differential diagnosis for Peyronie’s disease
Free
  1. Manoj Kumar Gupta1,
  2. Swaroop Revannasiddaiah2,
  3. Sridhar Papaiah Susheela3
  1. 1Regional Cancer Centre, Indira Gandhi Medical College, Shimla, India
  2. 2Department of Radiation Oncology, Swami Rama Cancer Hospital and Research Institute, Haldwani, Uttarakhand, India
  3. 3Department of Radiation Oncology, HealthCare Global-Bangalore Institute of Oncology, Bengaluru, Karnataka, India
  1. Correspondence to Dr Swaroop Revannasiddaiah, swarooptheone{at}gmail.com

https://doi.org/10.1136/bcr-2013-201446

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Description

    A healthy 36-year-old man reported with an abnormal penile erection where the erection curved to the right which he was noticed 6 months ago. He was diagnosed to be suffering from Peyronie’s disease (induratio penis plastica)1 by an urologist, who had performed clinical palpation, and had obtained confirmation via the use of ultrasonography and the intracavernosal injection test. Since the condition did not affect his sexual functions, he was offered no treatment.

    However, after a lapse of 2 months, he presented with breathlessness and haemoptysis. Evaluation revealed a mass in the right lung (figure 1) which on biopsy yielded an epidermal growth factor receptor mutated adenocarcinoma. A whole-body 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) scan revealed the disease to be disseminated to multiple sites including the liver, opposite lung and bilateral adrenal glands.

    Figure 1
    Figure 1

    CT (A) and positron emission tomography (B) demonstrating the metabolically active malignancy in the right lung.

    A surprise finding was of a highly avid metastatic focus (standardised uptake value (SUV): 14.6) in the penis (figure 2) which had been the cause of his curved penile erections. Cytological confirmation of the penile lesion was not resorted to since the extremely high FDG-avidity (SUV 14.6) was, in-itself, confirmatory. This is a very rare instance where in a disseminated lung cancer case there has been a differential diagnosis of ‘Peyronie’s disease’.

    Figure 2
    Figure 2

    Positron emission tomography demonstrating a metabolically active lesion in the penis (arrow).

    Given the disseminated condition of malignancy and the fragile general condition of the patient, he was initiated on oral tyrosine-kinase inhibitor (erlotinib) as palliative treatment. However, 5 weeks after initiation of disease, the patient succumbed owing to respiratory failure due to bilateral metastatic pulmonary dissemination.

    Learning points

    • Peyronie's disease, also known as ‘induratio penis plastica’, is a disease wherein the presence of fibrous plaques leads to erectile difficulties and abnormal penile curvature.1

    • In rare situations, metastatic malignant disease to the penis may lead to the onset of sudden and abrupt symptomatology resembling Peyronie's disease.

    • The use of FDG-PET scanning enables the detection of foci of distant metastases which may otherwise go unnoticed.

    Reference

    1. ↵
      1. Gelbard MK,
      2. Dorey F,
      3. James K
      . The natural history of Peyronie's disease. J Urol 1990;144:1376–9.
      OpenUrlPubMedWeb of Science
    View Abstract

    Footnotes

    • Contributors MKG wrote the manuscript. SR decided to report the case and provided the images. SPS prepared the final version of the manuscript.

    • Competing interests None.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.